Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

About the study

Primary Objective: To explore associations between biomarkers of atopic dermatitis (AD) and: * Disease state and time course of AD, * Disease state and evolution of selected atopic comorbid conditions, * Effectiveness of specific AD treatments.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion criteria:

Participation in the OBS15333 pediatric atopic dermatitis (AD) registry.
Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age.

EXCLUSION CRITERIA

Exclusion criteria:

Not applicable.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details

Contition

Dermatitis Atopic

Age (in years)

< 11

Participants needed

266

Est. Completion Date

Sep 30, 2026

Treatment type

OBSERVATIONAL

Sponsor

Sanofi

ClinicalTrials.gov identifier

NCT03849716

Study number

LPS15496

Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?